Tyler Dunn, PhD (he/him/his)

Evidence Generation Manager
Novo Nordisk, Inc.
Manasquan

Tyler J. Dunn, PhD, is the Evidence Generation Manager on the Diabetes Real-world Evidence team at Novo Nordisk Inc. Tyler's research work focuses on endocrinology and cardiovascular disease outcomes utilizing real-world data to improve patient care and outcomes.

Disclosure information not submitted.

Presentation(s):

• P109 - Comparing Characteristics and Prescribing Patterns Among Patients with T2D and Established ASCVD with and without Cardioprotective Medications

  Saturday, August 10, 2024
  12:15 PM – 1:15 PM CT